Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

4

Number of overlapping holdings

6.1%

% of HART's 75 holdings also in XPH

10.0%

% of XPH's 40 holdings also in HART

Overlap by Weight
Sector Drift (HART minus XPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in HART
Weight
in XPH
Overlap
ELI LILLY & CO 5.4% 4.0% 4.0%
JOHNSON & JOHNSON 5.3% 3.8% 3.8%
PFIZER INC 5.0% 3.7% 3.7%
BRISTOL-MYERS SQUIBB CO 5.1% 3.4% 3.4%

Position Highlights (Non-Overlapping Exposures)
HART Overweight Relative to XPH
ABBOTT LABORATORIES 5.7%
ASTRAZENECA PLC 5.6%
BOSTON SCIENTIFIC CORP 5.4%
MEDTRONIC PLC 5.4%
NOVARTIS AG 5.3%
ALPHABET INC. CLASS A 5.0%
APPLE INC 4.9%
SANOFI-AVENTIS 4.0%
NOVO NORDISK A/S-B 4.0%
ELEVANCE HEALTH INC 2.8%
HART Underweight Relative to XPH
CORCEPT THERAPEUTICS INC -5.3%
ROYALTY PHARMA PLC CLASS A -4.0%
ZOETIS INC -3.9%
PRESTIGE BRANDS HOLDINGS INC -3.8%
TARSUS PHARMACEUTICALS, INC. -3.8%
AXSOME THERAPEUTICS, INC. -3.7%
ELANCO ANIMAL HEALTH, INC. -3.7%
VIATRIS, INC. -3.7%
PERRIGO CO -3.7%
JAZZ PHARMACEUTICALS PLC -3.6%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY